AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Schizophrenia Patients

tACS for Self-Other Boundary in Schizophrenia NCT07818668NA1 site๐Ÿ“ Hefei Chunyan Zhu ยท Tests: Transcranial Alternating Current Stimulation (tACS), Sham Transcranial Alternating Current Stimulation (tACS) Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode NCT05384392NA5 sites๐Ÿ“ Angers๐Ÿ“ Brest๐Ÿ“ Nantes University Hospital, Brest ยท Tests: Recorded interview, Clinical scales, Blood sample A Long-term Administration Trial of SEP-363856 in Patients With Schizophrenia NCT07225712Phase 31 site๐Ÿ“ Fukuoka Otsuka Pharmaceutical Co., Ltd. ยท Tests: SEP-363856 Piloting of an Intervention to Reduce Problematic Alcohol Use in Early Phase Psychosis Patients NCT05365347NA1 site๐Ÿ“ Halifax Nova Scotia Health Authority ยท Tests: Cognitive Enhancement Therapy (CET) rTMS for Depressive, Positive and Negative Symptoms, and Physiological Indices of Schizophrenia Patients NCT05671185NA1 site๐Ÿ“ Douliu, Yunlin National Taiwan University Hospital ยท Tests: Repetitive Transcranial Magnetic Stimulation Cognitive Remediation Method Using Rhythmic, Vocal and Corporal Musical Learning for Schizophrenia NCT07055204NA6 sites๐Ÿ“ Bayonne๐Ÿ“ Bron๐Ÿ“ Marseille University Hospital, Toulouse ยท Tests: "Diapason & Metronome" musical learning Oxytocin-Augmented Group Psychotherapy for Patients With Schizophrenia - an Oxytocin-dose Comparison NCT07265180NA1 site๐Ÿ“ Berlin Charite University, Berlin, Germany ยท Tests: Oxytocin, Placebo Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use NCT05445180NA1 site๐Ÿ“ Montreal Douglas Mental Health University Institute ยท Tests: Contingency management Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder NCT07213466Phase 41 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Group Therapy Program, semaglutide, Phentermine-Topiramate, naltrexone and bupropion (combination) App and Body Fat Scale in the Management of Overweight Patients NCT05866107NA1 site๐Ÿ“ Beijing Capital Medical University ยท Tests: Effectiveness and Feasibility of Self-Monitoring for Weight Management in Individuals with Mental Disorders Using Digitโ€ฆ Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations NCT05299749NA1 site๐Ÿ“ Brockton Boston VA Research Institute, Inc. ยท Tests: stg-rt-fMRI-Neurofeeback, sham-rt-fMRI-Neurofeedback Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life NCT07306468n/a1 site๐Ÿ“ ร‡ankฤฑrฤฑ ร‡ankฤฑrฤฑ Karatekin University ยท Tests: Pulmonary Function Test, Respiratory Muscle Strength Evaluation, Quality of Life Assessment, Exercise Capacity Assessmeโ€ฆ Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia NCT06174116Phase 41 site๐Ÿ“ Worcester University of Massachusetts, Worcester ยท Tests: Lumateperone, Placebo Study of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability NCT04945278NA1 site๐Ÿ“ Bohars University Hospital, Brest ยท Tests: Double mirror device ALTER-EGO, EASE test fMRI-based Neurofeedback to Relieve Drug-resistant Auditory Hallucinations NCT04798131NA1 site๐Ÿ“ Lille University Hospital, Lille ยท Tests: Active neurofeedback procedure, Sham neurofeedback procedure The Danish Region Midt Schizophrenia Cohort NCT06431009n/a5 sites๐Ÿ“ Aarhus๐Ÿ“ Herning๐Ÿ“ Horsens University of Aarhus ยท Tests: Treatment-as-usual Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With Schizophrenia NCT07484204Phase 14 sites๐Ÿ“ Ahmedabad๐Ÿ“ Ahmedabad๐Ÿ“ Gandhinagar Anxo Pharmaceutical Co., Ltd. ยท Tests: AX251 LAI 45 mg, AX251 LAI 90 mg, AX251 LAI 135 mg, AX251 LAI 180 mg Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia NCT07184619Phase 319 sites๐Ÿ“ Los Angeles๐Ÿ“ Miami๐Ÿ“ Atlanta Newron Pharmaceuticals SPA ยท Tests: Evenamide 15 mg bid, Placebo Digital Therapeutics for Social Cognitive Function in Schizophrenia Spectrum Disorder NCT07755605NA1 site๐Ÿ“ Seoul Samsung Medical Center ยท Tests: Digital therapeutic (AffectUs), Psychoeducational materials iTBS for Increased Appetite Induced by Antipsychotics NCT05783063NA2 sites๐Ÿ“ Changsha๐Ÿ“ Dali Central South University ยท Tests: Active iTBS, Sham iTBS Restoring Spindle and Thalamocortical Efficiency in Early-Course Schizophrenia Patients Using Auditory Stimulation NCT05956951NA1 site๐Ÿ“ Pittsburgh Fabio Ferrarelli ยท Tests: Closed-loop auditory stimulation, Sham auditory stimulation Develop a Novel Occupational Training Program for Schizophrenia Patients Based on Virtual Reality Techniques NCT05830903NA1 site๐Ÿ“ Taipei National Taiwan University Hospital ยท Tests: VR-assisted occupational training An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia NCT02640911n/a1 site๐Ÿ“ Shanghai Shanghai Mental Health Center A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor NCT07105111Phase 419 sites๐Ÿ“ Bryant๐Ÿ“ Chino๐Ÿ“ Fresno Neurocrine Biosciences ยท Tests: Valbenazine A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia NCT06821945Phase 22 sites๐Ÿ“ Daegu๐Ÿ“ Guri-si Boryung Pharmaceutical Co., Ltd ยท Tests: BR5402A, BR5402A-1, BR5402B, BR5402B-1, BR5402C Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia NCT03911726NA1 site๐Ÿ“ Mannheim Central Institute of Mental Health, Mannheim ยท Tests: Single PET/MR-measurement Creating a Global Research Database That Connects Genetic Information and Long-term Health Data to Improve Personalized Treatment for People With Serious Mental Illness NCT06641726n/a1 site๐Ÿ“ Oxford Akrivia Health ยท Tests: Not applicable- observational study Clozapine-related Immunodeficiency in Parkinsons Disease NCT06634641Phase 41 site๐Ÿ“ Salouรซl Centre Hospitalier Universitaire, Amiens ยท Tests: blood test Virtual Reality and Artificial Intelligence in Treatment for Patients With Psychosis NCT06728241NA2 sites๐Ÿ“ Oslo๐Ÿ“ Nydalen Oslo University Hospital ยท Tests: RecoVRy, VR Games Effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic NCT06624462NA1 site๐Ÿ“ Glostrup Municipality Bjorn H. Ebdrup ยท Tests: Treatment in the Meta Care Clinic, Standard care with general practitioner and/or outpatient clinics
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy